Search

everythinglearnresearchcommunity

for

Search:↓

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Skin symptoms are important for diagnosing infections in children.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Higher leptin levels link to hair loss.

Higher RBP4 levels found in people with two types of hair loss.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Botulinum and tetanus neurotoxins are better understood now, with updated information on their effects and treatment.

Polyamines are abundant in certain parts of rat hair follicles and may play a key role in hair growth.

Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Hair follicles help skin immune recovery after UVB exposure.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Nivolumab can cause hair loss as a rare side effect.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

TrichoTech™ may help hair growth and skin repair by increasing fibroblast growth and activity.

Researchers developed a new method to clearly see and label hair proteins with minimal errors using advanced freezing and microscopy techniques.